The Vanguard Mega Cap Growth ETF (MGK) has an implied analyst target price of $98.64 per unit, representing a 16.38% upside from its recent trading price of $84.75. This analysis was conducted based on the underlying holdings of the ETF and their respective average analyst 12-month target prices.
Notable stocks contributing to this potential upside include Boston Scientific Corp. (BSX), with a recent price of $56.50 and a target of $85.78 (51.83% upside); Vertex Pharmaceuticals, Inc. (VRTX), currently at $423.92 with a target of $550.39 (29.83% upside); and Intuitive Surgical Inc. (ISRG), trading at $457.78 and targeting $589.00 (28.66% upside).
Investors are encouraged to consider whether analysts’ targets are justified based on market conditions and company performance as they plan their investment strategies over the next 12 months.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
